Back to Search
Start Over
Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC
- Source :
- Annals of Oncology. 30:ii79-ii80
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
Details
- ISSN :
- 09237534
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........7aa39c9d086404b02d6a552c3ffc245a